Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Molecular targeted therapy for cancer].
Sone S, Kuramoto T, Sato S, Mitsuhashi A, Kakiuchi S, Goto H, Tada H, Nishioka Y. Sone S, et al. Among authors: mitsuhashi a. Nihon Rinsho. 2010 Jun;68(6):997-1006. Nihon Rinsho. 2010. PMID: 20535947 Review. Japanese.
The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
Van TT, Hanibuchi M, Kakiuchi S, Sato S, Kuramoto T, Goto H, Mitsuhashi A, Nishioka Y, Akiyama S, Sone S. Van TT, et al. Among authors: mitsuhashi a. Cancer Chemother Pharmacol. 2011 Aug;68(2):497-504. doi: 10.1007/s00280-010-1503-x. Epub 2010 Nov 16. Cancer Chemother Pharmacol. 2011. PMID: 21079960 Free PMC article.
Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-κB activity.
Kuramoto T, Goto H, Mitsuhashi A, Tabata S, Ogawa H, Uehara H, Saijo A, Kakiuchi S, Maekawa Y, Yasutomo K, Hanibuchi M, Akiyama S, Sone S, Nishioka Y. Kuramoto T, et al. Among authors: mitsuhashi a. Mol Cancer Ther. 2012 Dec;11(12):2578-87. doi: 10.1158/1535-7163.MCT-12-0640. Epub 2012 Sep 18. Mol Cancer Ther. 2012. PMID: 22989420
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab.
Mitsuhashi A, Goto H, Saijo A, Trung VT, Aono Y, Ogino H, Kuramoto T, Tabata S, Uehara H, Izumi K, Yoshida M, Kobayashi H, Takahashi H, Gotoh M, Kakiuchi S, Hanibuchi M, Yano S, Yokomise H, Sakiyama S, Nishioka Y. Mitsuhashi A, et al. Nat Commun. 2015 Dec 4;6:8792. doi: 10.1038/ncomms9792. Nat Commun. 2015. PMID: 26635184 Free PMC article.
Thymidine Catabolism as a Metabolic Strategy for Cancer Survival.
Tabata S, Yamamoto M, Goto H, Hirayama A, Ohishi M, Kuramoto T, Mitsuhashi A, Ikeda R, Haraguchi M, Kawahara K, Shinsato Y, Minami K, Saijo A, Hanibuchi M, Nishioka Y, Sone S, Esumi H, Tomita M, Soga T, Furukawa T, Akiyama SI. Tabata S, et al. Among authors: mitsuhashi a. Cell Rep. 2017 May 16;19(7):1313-1321. doi: 10.1016/j.celrep.2017.04.061. Cell Rep. 2017. PMID: 28514652 Free article.
128 results